FindMyKOL
Clinical trialNCT00000620CompletedPhase 3Interventional

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

SponsorNational Heart, Lung, and Blood Institute (NHLBI)Enrollment10,251AtherosclerosisCardiovascular DiseasesCoronary DiseaseDiabetes MellitusDiabetes Mellitus, Type 2Hypercholesterolemia+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Mcmaster University

    Hamilton, Ontario, Canada

United States
  • Minneapolis Medical Research Foundation

    Minneapolis, Minnesota, United States

  • Columbia University

    New York, New York, United States

  • Wake Forest University

    Winston-Salem, North Carolina, United States

  • Case Western Reserve University

    Cleveland, Ohio, United States

  • Veterans Affairs

    Memphis, Tennessee, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Anti-hyperglycemic AgentsAnti-hypertensive AgentsBlinded fenofibrate or placebo plus simvastatin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 1999
Primary completion
30 Jun 2009
Completion
31 Dec 2012
Last update posted
22 Nov 2016
Registered enrollment
10,251
Registry id
NCT00000620
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.